Table 2.
Summary of Study Characteristics
| Male | fQRS (+) | QRS | Follow | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | Gender | ST/NS | ECG | ratio, | width (ms) | LV EF, % | ‐up, | Death,n | MACE, | |||
| Name | n | Type | fQRS +/– | fQRS +/– | TEMI | Time | n (%) | fQRS +/− | fQRS +/– | Months | fQRS +/– | n fQRS +/– |
| Arı 2012 | 85 | Prosp | 54/55 | 29/41 | 85/0 | 48 | 34 (40) | 73/68 | 39/43 | 6.6 ± 2.3 | NR | 10/3 |
| Guo 10 | 179 | Retro | 62/60 | 66/47 | 0/179 | 48 | 106 (59) | NR | 57.2/57.1 | 10.2 | 18/4 | 46/22 |
| Lorgis 11 | 307 | Retro | 71/62 | 103/113 | 129/178 | 36 | 145 (47) | 80/80 | 55/50 | 28.2 | 25/17 | 72/20 |
| Yıldırım 2013 | 355 | Prosp | 59/55 | 175/90 | 355/0 | 48 | 217 (61) | NR | 42/50 | In‐hospital | 14/0 | 55/9 |
| Bekler 12 | 149 | Retro | 64/59 | 38/74 | 0/149 | Adm | 46 (31) | NR | 46/50 | 18 | 12/9 | 33/20 |
| Akgul 2014 | 414 | Prosp | 60/53 | 59/269 | 414/0 | 48 | 91 (22) | 94/88 | 44/49 | 12 | 22/7 | 37/39 |
| Sheng 13 | 300 | Retro | 68 (total) | 204 (total) | 99/201 | 48 | 169 (56) | NR | NR | In‐hospital | 40/19 | NR |
| Stavileci 14 | 296 | Retro | 61/61 | 70/156 | 296/0 | Adm | 80 (27) | NR | 37/44 | In‐hospital | 16/12 | NR |
| Tanrıverdi 18 | 248 | Retro | 65/62 | 69/120 | 248/0 | 48 | 91 (37) | 108/102 | 35/47 | In‐hospital | 13/7 | NR |
| Bozbeyoğlu 17 | 433 | Prosp | 63/62 | 59/231 | 0/433 | Adm | 85 (20) | 103/95 | 45/50 | In‐hospital,12 months | 12/17 | NR |
ADM = admission; ECG = electrocardiography; LV EF = left ventricular ejection fraction; MACE = major adverse cardiovascular events; NSTEMI = non‐ST segment myocardial infarction; NR = not reported; Prosp = prospective; Retro = retrospective; STEMI = ST segment myocardial infarction.